Short Interest in DarioHealth Corp. (NASDAQ:DRIO) Rises By 32.2%

DarioHealth Corp. (NASDAQ:DRIO) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 80,370 shares, a growth of 32.2% from the December 15th total of 60,781 shares. Based on an average daily volume of 33,153 shares, the short-interest ratio is currently 2.4 days. Approximately 1.2% of the shares of the company are sold short. Approximately 1.2% of the shares of the company are sold short. Based on an average daily volume of 33,153 shares, the short-interest ratio is currently 2.4 days.

DarioHealth Trading Up 1.8%

NASDAQ DRIO traded up $0.22 during mid-day trading on Monday, reaching $12.44. 4,058 shares of the stock were exchanged, compared to its average volume of 22,980. The business’s fifty day simple moving average is $11.95 and its 200 day simple moving average is $12.05. The company has a debt-to-equity ratio of 0.41, a quick ratio of 4.02 and a current ratio of 4.55. The stock has a market capitalization of $84.09 million, a PE ratio of -1.11 and a beta of 1.05. DarioHealth has a 1-year low of $5.93 and a 1-year high of $17.74.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DRIO shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Stifel Nicolaus set a $16.00 price target on DarioHealth in a research note on Friday, November 14th. Cowen reissued a “hold” rating on shares of DarioHealth in a research note on Friday, November 14th. Finally, Wall Street Zen upgraded shares of DarioHealth from a “sell” rating to a “hold” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $32.00.

Institutional Trading of DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. XTX Topco Ltd grew its stake in shares of DarioHealth Corp. (NASDAQ:DRIO) by 229.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,511 shares of the company’s stock after purchasing an additional 43,513 shares during the period. XTX Topco Ltd owned about 0.14% of DarioHealth worth $42,000 as of its most recent SEC filing. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.